Generative Unconstrained Intelligence Drug Engineering (Guide) Collaboration Between U.S. Interagency, Academic And Industry Partners

DEPT OF DEFENSE United States has Released a tender for Generative Unconstrained Intelligence Drug Engineering (Guide) Collaboration Between U.S. Interagency, Academic And Industry Partners in . The tender was released on Jun 14, 2025.

Country - United States

Summary - Generative Unconstrained Intelligence Drug Engineering (Guide) Collaboration Between U.S. Interagency, Academic And Industry Partners

Deadline - Oct 18, 2028

MT reference number - 111035374

Product classification - Research and development consultancy services

Organization Details:

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 111035374

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enablin g Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning

Mt Ref Id - 111035374

Deadline - Oct 18, 2028

Share

Similar Tenders :